Cardiac PET Imaging: When It’s the Right Test at the Right Time

Overview

Diagnosing and treating patients well starts with choosing the most precise test. Cardiac PET imaging is the test of choice more often these days when it comes to assessing coronary artery disease, myocardial perfusion, viability and ventricular function in more complex patients. It makes sense clinically, operationally and financially. It also trumps SPECT in many ways, and can even play a role in cardiac disease prevention.

Learn from this panel of experts about which patients benefit most and the advantages cardiac PET brings in:

Myocardial blood flow assessment in detecting coronary artery disease
Assessing viable myocardium in dysfunctional left ventricular regions, examining transplants and vasculopathy
Detecting cardiac sarcoidosis and infections in implanted cardiac devices
Even avoiding unnecessary interventional procedures

For physicians and administrators alike, cardiac PET can add value to clinical practice and patient and practice management.

Learning Objectives

What types of patients can benefit most from cardiac PET
Methods for selecting patients to ensure diagnostic precision
How departments can benefit from cardiac PET as a one-stop shop for risk stratification
Why quantitative assessment of absolute hyperemic myocardial blood flow and flow reserve improves the diagnostic accuracy for detecting single or multi-vessel CAD
Why cardiac PET improves clinical confidence
How imaging can help to get patients out of the ED, ICU or hospital more quickly
Why the economics work well in a value-based environment
How to avoid unnecessary studies
Defining and achieving quality outcomes

Target Audience

Chiefs of Cardiology
Cardiologists and Interventional Cardiologists
Cardiology Service Line Directors
Cardiovascular Administrators
Hospital and Health System Administrators

Presenters:

	Vasken Dilsizian, MD Professor of Medicine and Radiology University of Maryland School of Medicine		Timothy Bateman, MD Co-Director, Cardiovascular Radiology Mid America Heart Institute Professor of Medicine University of Missouri at Kansas City
	Randall Thompson, MD Consultant Cardiologist Mid America Heart Institute Professor of Medicine University of Missouri at Kansas City		Patrick Bering, MD Chief Cardiology Fellow University of Maryland Medical Center

19 more things you need to know about cardiac PET!
(hint: we answered ALL the webinar audience questions)

It was a good problem to have. We had way too questions proposed during the webinar expert Q&A than we could answer. So we reconvened the expert panel with Drs. Dilsizian, Bateman, Thompson and Bering to answer them ALL! Check out the bonus answers—on reimbursement, patient selection, building physician awareness, timing for new agents on the horizon, the challenge of PET/MR and cardiac PET’s role in retasking the cath lab and even cardiac PET serving as gatekeeper. Take a look!